Found: 24
Select item for more details and to access through your institution.
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.3390/jpm10040290
- By:
- Publication type:
- Article
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25708-y
- By:
- Publication type:
- Article
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.
- Published in:
- Acta Neuropathologica Communications, 2015, v. 3, n. 1, p. 121, doi. 10.1186/s40478-015-0201-7
- By:
- Publication type:
- Article
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40235-8
- By:
- Publication type:
- Article
Accurate calling of KIAA1549‐BRAF fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data.
- Published in:
- Neuropathology & Applied Neurobiology, 2021, v. 47, n. 3, p. 406, doi. 10.1111/nan.12683
- By:
- Publication type:
- Article
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 226, doi. 10.1093/neuonc/noaa191
- By:
- Publication type:
- Article
MEDU-01. HDACi AND PLK1i ACT SYNERGISTICALLY IN MYC-AMPLIFIED MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii103, doi. 10.1093/neuonc/noz036.161
- By:
- Publication type:
- Article
GENE-12. ANAPLASTIC NEUROEPITHELIAL TUMOR WITH CONDENSED NUCLEI (ANTCON): A NOVEL BRAIN TUMOR ENTITY WITH RECURRENT NTRK FUSION.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii83, doi. 10.1093/neuonc/noz036.083
- By:
- Publication type:
- Article
A synergistic interaction between HDAC‐ and PARP inhibitors in childhood tumors with chromothripsis.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 4, p. 590, doi. 10.1002/ijc.34027
- By:
- Publication type:
- Article
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors.
- Published in:
- Brain Pathology, 2016, v. 26, n. 4, p. 506, doi. 10.1111/bpa.12326
- By:
- Publication type:
- Article
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 904, doi. 10.1002/cpt.3002
- By:
- Publication type:
- Article
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. 1, doi. 10.1186/s13148-019-0775-1
- By:
- Publication type:
- Article
Retinoblastoma with late metastatic spread-a case report.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 5, p. 667, doi. 10.1007/s00401-023-02558-0
- By:
- Publication type:
- Article
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 1, p. 97, doi. 10.1007/s00401-022-02522-4
- By:
- Publication type:
- Article
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
- Published in:
- Acta Neuropathologica, 2021, v. 142, n. 6, p. 1065, doi. 10.1007/s00401-021-02369-1
- By:
- Publication type:
- Article
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.
- Published in:
- Acta Neuropathologica, 2019, v. 138, n. 5, p. 827, doi. 10.1007/s00401-019-02039-3
- By:
- Publication type:
- Article
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 1, p. 99, doi. 10.1007/s11060-023-04526-w
- By:
- Publication type:
- Article
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 3, p. 467, doi. 10.1007/s11060-023-04500-6
- By:
- Publication type:
- Article
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 617, doi. 10.1007/s11060-023-04445-w
- By:
- Publication type:
- Article
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 1, p. 143, doi. 10.1007/s11060-023-04319-1
- By:
- Publication type:
- Article
Response to trametinib treatment in progressive pediatric low-grade glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 149, n. 3, p. 499, doi. 10.1007/s11060-020-03640-3
- By:
- Publication type:
- Article
Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 12, p. 2273, doi. 10.1093/neuonc/noad114
- By:
- Publication type:
- Article
Sarcoma classification by DNA methylation profiling.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20603-4
- By:
- Publication type:
- Article